Wegman Toby
Director, 10% owner at BIOSPECIFICS TECHNOLOGIES CORP
- Sold, on record
- $20.1M
- Dollars the filings state
- Form 4 sales
- 24
- Latest Sep 10, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BIOSPECIFICS TECHNOLOGIES CORPDirector, 10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not statedAug 30, 2016 2016
Sold 4,299 shares at $37.54 ($161k)
Wegman Toby, President
Sold 0.4% of holdings ($36.8M position)975,879 shares left0.4x usual sizeFiling
- 2 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not statedSep 2, 2016 +3 days
Sold 9,201 shares at $37.53 ($345k)
Wegman Toby, President
Sold 0.9% of holdings ($36.6M position)966,678 shares left1.1x usual sizeFiling
- 3 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not statedSep 13, 2016 +11 days
Sold 3,605 shares at $37.55 ($135k)
Wegman Toby, Director
Sold 0.4% of holdings ($36.3M position)963,073 shares left0.4x usual sizeFiling
- 4 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not statedSep 15, 2016 +2 days
Sold 3,100 shares at $41.21 ($128k)
Wegman Toby, Director
Sold 0.3% of holdings ($39.7M position)959,973 shares left0.5x usual sizeFiling
- 5 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not statedNov 29, 2016 +75 days
Sold 10,000 shares at $48.08 ($481k)
Wegman Toby, Director
Sold 1% of holdings ($46.2M position)949,973 shares left2.5x usual sizeFiling
- 6 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not statedAug 17, 2018 +626 days
Sold 2,500 shares at $51.89 ($130k)
Wegman Toby, Director, 10% owner
Sold 0.3% of holdings ($49.3M position)947,473 shares left0.6x usual sizeFiling
- 7 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not statedMay 21, 2019 +277 days
Sold 5,500 shares at $64.06 ($352k)
Wegman Toby, Director, 10% owner
Sold 0.6% of holdings ($60.9M position)945,073 shares leftFiling
- 8 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not statedSep 10, 2019 +112 days
Sold 10,000 shares at $55.17 ($552k)
Wegman Toby, Director, 10% owner
Sold 1.1% of holdings ($52.1M position)935,073 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (24)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2019 | Sep 10, 2019 | BIOSPECIFICS TECHNOLOGIES CORP | Director, 10% owner | Form 4 sale | 10,000 | $552k | 1.1% | Plan not stated | SEC |
| May 21, 2019 | May 22, 2019 | BIOSPECIFICS TECHNOLOGIES CORP | Director, 10% owner | Form 4 sale | 5,500 | $352k | 0.6% | Plan not stated | SEC |
| Aug 17, 2018 | Aug 17, 2018 | BIOSPECIFICS TECHNOLOGIES CORP | Director, 10% owner | Form 4 sale | 2,500 | $130k | 0.3% | Plan not stated | SEC |
| Nov 29, 2016 | Nov 29, 2016 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 10,000 | $481k | 1.0% | Plan not stated | SEC |
| Sep 15, 2016 | Sep 16, 2016 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 3,100 | $128k | 0.3% | Plan not stated | SEC |
| Sep 13, 2016 | Sep 13, 2016 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 3,605 | $135k | 0.4% | Plan not stated | SEC |
| Sep 2, 2016 | Sep 2, 2016 | BIOSPECIFICS TECHNOLOGIES CORP | President | Form 4 sale | 9,201 | $345k | 0.9% | Plan not stated | SEC |
| Aug 30, 2016 | Aug 30, 2016 | BIOSPECIFICS TECHNOLOGIES CORP | President | Form 4 sale | 4,299 | $161k | 0.4% | Plan not stated | SEC |
| May 18, 2016 | May 19, 2016 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 25,000 | $825k | 2.5% | Plan not stated | SEC |
| Dec 2, 2014 | Dec 4, 2014 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 2,950 | $116k | 63.3% | Unusual | SEC |
| Nov 24, 2014 | Nov 25, 2014 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 12,050 | $471k | 72.1% | Unusual | SEC |
| Jun 15, 2012 | Jun 18, 2012 | BIOSPECIFICS TECHNOLOGIES CORP | Director, 10% owner | Form 4 sale | 6,339 | $116k | 78.7% | Unusual | SEC |
| Jun 11, 2012 | Jun 13, 2012 | BIOSPECIFICS TECHNOLOGIES CORP | Director, 10% owner | Form 4 sale | 1,500 | $27k | 15.7% | Plan not stated | SEC |
| Jun 6, 2012 | Jun 8, 2012 | BIOSPECIFICS TECHNOLOGIES CORP | Director, 10% owner | Form 4 sale | 101 | $2k | 1.0% | Plan not stated | SEC |
| Jun 4, 2012 | Jun 5, 2012 | BIOSPECIFICS TECHNOLOGIES CORP | Director, 10% owner | Form 4 sale | 2,500 | $43k | 20.6% | Plan not stated | SEC |
| May 30, 2012 | May 31, 2012 | BIOSPECIFICS TECHNOLOGIES CORP | Director, 10% owner | Form 4 sale | 121 | $2k | 1.0% | Plan not stated | SEC |
| May 22, 2012 | May 24, 2012 | BIOSPECIFICS TECHNOLOGIES CORP | Director, 10% owner | Form 4 sale | 1,000 | $16k | 7.5% | Plan not stated | SEC |
| May 17, 2012 | May 18, 2012 | BIOSPECIFICS TECHNOLOGIES CORP | Director, 10% owner | Form 4 sale | 1,725 | $28k | 11.5% | Plan not stated | SEC |
| Sep 13, 2010 | Sep 15, 2010 | BIOSPECIFICS TECHNOLOGIES CORP | Director, 10% owner | Form 4 sale | 150,000 | $3.5M | 13.0% | Plan not stated | SEC |
| Nov 27, 2009 | Dec 1, 2009 | BIOSPECIFICS TECHNOLOGIES CORP | Director, 10% owner | Form 4 sale | 100,000 | $3M | 8.0% | Plan not stated | SEC |
| Sep 15, 2009 | Sep 17, 2009 | BIOSPECIFICS TECHNOLOGIES CORP | Director, 10% owner | Form 4 sale | 100,000 | $2.4M | 7.4% | Plan not stated | SEC |
| Feb 5, 2009 | Feb 11, 2009 | BIOSPECIFICS TECHNOLOGIES CORP | Director, 10% owner | Form 4 sale | 45,000 | $900k | 3.2% | Plan not stated | SEC |
| Apr 7, 2008 | Apr 9, 2008 | BIOSPECIFICS TECHNOLOGIES CORP | Director, 10% owner | Form 4 sale | 200,000 | $2.2M | 14.0% | Plan not stated | SEC |
| Feb 1, 2008 | Feb 5, 2008 | BIOSPECIFICS TECHNOLOGIES CORP | Director, 10% owner | Form 4 sale | 344,114 | $4.1M | 21.9% | Plan not stated | SEC |